- Advanced search
- Guide to IMMUNOPHARMACOLOGY Portal
Molecular properties generated using the CDK
|Compound class||Synthetic organic|
|SIM-010603 | SIM010603|
|Tafetinib (SIM010603) is an orally active inhibitor of multiple receptor tyrosine kinases (RTKs) that was developed as an antineoplatic agent . Some of its main targets are KIT, VEGFR, PDGFRβ, RET, and FLT3. It produces anti-angiogenic and anti-tumor effects in vitro and in vivo.
Tafetinib is a 'pseudo' INN, that takes the form of an INN, but has not been submitted to the World Health Organisation for ratification.
|CAS Registry No.||1032265-57-8 (source: PubChem)|
|GtoPdb PubChem SID||363894215|
|Search Google for chemical match using the InChIKey||KGSRYTUWXUESJK-FXBPSFAMSA-N|
|Search Google for chemicals with the same backbone||KGSRYTUWXUESJK|
|Search UniChem for chemical match using the InChIKey||KGSRYTUWXUESJK-FXBPSFAMSA-N|
|Search UniChem for chemicals with the same backbone||KGSRYTUWXUESJK|